Investigators from the Consejo Superior de Investigaciones Científicas (CSIC) have shown that myocardial ischemia (a decrease of blood flow and therefore oxygen, reaching the heart) triggers an acute inflammatory response to cardiac and systemic. Since inflammation is an indicator of future cardiovascular problems, study results, published in Journal of Thrombosis and Haemostasis, reinforcing the need to design pharmacological strategies aimed at reducing the inflammatory response after stroke.
Using a pig experimental model of acute myocardial infarction, researchers at the Cardiovascular Research Center (center joint CSIC and Institut Català de Ciències Cardiovasculars in Barcelona) have shown that short periods of coronary occlusion induced an increase in the levels of proinflammatory cytokines greater activation of mononuclear cells present in blood and increased plaque reactivity.
Investigators from the Consejo Superior de Investigaciones Científicas (CSIC) have shown that myocardial ischemia (a decrease of blood flow and therefore oxygen, reaching the heart) triggers an acute inflammatory response to cardiac and systemic. Since inflammation is an indicator of future cardiovascular problems, study results, published in Journal of Thrombosis and Haemostasis, reinforcing the need to design pharmacological strategies aimed at reducing the inflammatory response after stroke.
Using a pig experimental model of acute myocardial infarction, researchers at the Cardiovascular Research Center (center joint CSIC and Institut Català de Ciències Cardiovasculars in Barcelona) have shown that short periods of coronary occlusion induced an increase in the levels of proinflammatory cytokines greater activation of mononuclear cells present in blood and increased plaque reactivity.
A team led by researcher at the Consejo Superior de Investigaciones Científicas (CSIC) Belén Peral has conducted the first comparative analysis of protein expression between the two adipose tissues of the human body, subcutaneous fat and omental fat, one that accumulates in the peritoneum (membrane that lines the abdomen) and, according to recent studies, is more related to abdominal obesity and various metabolic diseases that are due to excess weight. The work has appeared prominently in Journal of Proteome Research.
Peral, who works at the Instituto de Investigaciones Biomédicas Alberto Sols (CSIC joint center and the Autonomous University of Madrid), has worked with groups from the Hospital Josep Trueta de Girona, CIBER of Obesity (CIBERobn) and the National Center for Cardiovascular Research Madrid.
A team led by researcher at the Consejo Superior de Investigaciones Científicas (CSIC) Belén Peral has conducted the first comparative analysis of protein expression between the two adipose tissues of the human body, subcutaneous fat and omental fat, one that accumulates in the peritoneum (membrane that lines the abdomen) and, according to recent studies, is more related to abdominal obesity and various metabolic diseases that are due to excess weight. The work has appeared prominently in Journal of Proteome Research.
Peral, who works at the Instituto de Investigaciones Biomédicas Alberto Sols (CSIC joint center and the Autonomous University of Madrid), has worked with groups from the Hospital Josep Trueta de Girona, CIBER of Obesity (CIBERobn) and the National Center for Cardiovascular Research Madrid.
Exxon Mobil Corporation announced a partnership with the biotech company, Synthetic Genomics Inc. (SGI), to research and develop next-generation biofuels derived from photosynthetic algae.
"This investment is taking place after several years of planning and research, and adds significantly to the ongoing efforts of ExxonMobil to advance innovative technologies that help address the energy challenges of the world," said Dr. Emil Jacobs, vice president of research and development for ExxonMobil Research and Engineering Company.
Exxon Mobil Corporation announced a partnership with the biotech company, Synthetic Genomics Inc. (SGI), to research and develop next-generation biofuels derived from photosynthetic algae.
"This investment is taking place after several years of planning and research, and adds significantly to the ongoing efforts of ExxonMobil to advance innovative technologies that help address the energy challenges of the world," said Dr. Emil Jacobs, vice president of research and development for ExxonMobil Research and Engineering Company.